BR0206650A - Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto - Google Patents

Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto

Info

Publication number
BR0206650A
BR0206650A BR0206650-5A BR0206650A BR0206650A BR 0206650 A BR0206650 A BR 0206650A BR 0206650 A BR0206650 A BR 0206650A BR 0206650 A BR0206650 A BR 0206650A
Authority
BR
Brazil
Prior art keywords
compound
optionally substituted
substituent
groups
substituent group
Prior art date
Application number
BR0206650-5A
Other languages
English (en)
Inventor
Tomio Kimura
Nobuyuki Ohkawa
Akira Nakao
Takayoshi Nagasaki
Takanori Yamazaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0206650A publication Critical patent/BR0206650A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, USO DE PELO MENOS UM COMPOSTO, E, PROCESSO PARA A PREPARAçãO DE UM COMPOSTO". Compostos de fórmula (I): [em que: A é um anel pirrol; R^ 1^ é um grupo arila ou heteroarila opcionalmente substituído; R^ 2^ é um grupo heteroarila contendo-nitrogênio opcionalmente substituído; e R^ 3^ é fórmulas (IIa), (IIb) ou (IIc), em que m é 1 ou 2, um de D e E é nitrogênio e o outro >C(R^ 5^)- (em que R^ 5^ é hidrogênio, um Substituinte <244> ou um Substituinte <225>, B é um anel heterocíclico contendo-nitrogênio com de 4 a 7 membros, e R^ 4^ é de 1 a 3 substituintes do Grupo substituinte <244>, Grupo substituinte <225> e Grupo substituinte <sym>; DESDE QUE R^ 1^ e R^ 3^ sejam ligados aos dois átomos do referido anel pirrol que são adjacentes ao átomo do anel pirrol ao qual referido substituinte R^ 2^ está ligado; Grupo substituinte <244> consiste de grupos hidroxila, nItro, ciano, halogênio, alcóxi, halogênio alcóxi, alquiltio e halogênio alquiltio e grupos de fórmula -NR^ a^R^ B^ (em que R^ a^ e R^ b^, são hidrogênio, alquila, alquenila, alquinila, aralquila e alquilsulfonila, ou R^ a^ e R^ b^, em conjunto com o átomo de nitrogênio ao qual estão ligados, formam um heterociclila); Grupo substituinte <225> consiste de grupos alquila, alquenila e alquinila opcionalmente substituídos, e grupos aralquila e cicloalquila; Grupo de substituintes <sym> consiste de grupos oxo, hidroxiimino, alcoxiimino, alquileno, alquilenodióxi, alquilsulfinila, alquilsulfonila, arila opcionalmente substituído, arilóxi opcionalmente substituído, alquilidenila e aralquilidenila] apresentam excelente atividade contra a produção de citocinas inflamatórias.
BR0206650-5A 2001-01-22 2002-01-22 Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto BR0206650A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001013817 2001-01-22
US27500501P 2001-03-12 2001-03-12
PCT/IB2002/000176 WO2002057264A1 (en) 2001-01-22 2002-01-22 Pyrrole derivates for treating cytokine mediated diseases

Publications (1)

Publication Number Publication Date
BR0206650A true BR0206650A (pt) 2004-02-25

Family

ID=26608097

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206650-5A BR0206650A (pt) 2001-01-22 2002-01-22 Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto

Country Status (21)

Country Link
EP (1) EP1377577B1 (pt)
KR (1) KR20030076619A (pt)
CN (1) CN100371336C (pt)
AR (1) AR032511A1 (pt)
AT (1) ATE329915T1 (pt)
BR (1) BR0206650A (pt)
CA (1) CA2435692A1 (pt)
CZ (1) CZ20031949A3 (pt)
DE (1) DE60212357T2 (pt)
EG (1) EG23054A (pt)
ES (1) ES2266500T3 (pt)
HU (1) HUP0302807A2 (pt)
IL (1) IL156861A0 (pt)
MX (1) MXPA03006515A (pt)
NO (1) NO20033290L (pt)
NZ (1) NZ527099A (pt)
PE (1) PE20030197A1 (pt)
PL (1) PL362896A1 (pt)
RU (1) RU2003122364A (pt)
SK (1) SK9282003A3 (pt)
WO (1) WO2002057264A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015781A1 (fr) * 2001-08-15 2003-02-27 Sankyo Company, Limited Nouvelles compositions pharmaceutiques antidiabetiques
EP1541571A4 (en) * 2002-07-19 2008-12-03 Sankyo Co BICYCLIC, UNSATURATED TERTIARY AMINE COMPOUND
SI1830869T1 (sl) 2004-12-24 2013-12-31 Spinifex Pharmaceuticals Pty Ltd Postopek zdravljenja ali profilakse
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions
CA2866540A1 (en) 2006-03-20 2007-09-27 Spinifex Pharmaceuticals Pty Ltd. Method of treatment or prophylaxis of inflammatory pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792778A (en) * 1995-08-10 1998-08-11 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU699148B2 (en) * 1995-08-10 1998-11-26 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
US5837719A (en) * 1995-08-10 1998-11-17 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
IL137365A0 (en) * 1999-07-21 2001-07-24 Sankyo Co Heteroaryl-substituted pyrrole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
IL156861A0 (en) 2004-02-08
CA2435692A1 (en) 2002-07-25
PL362896A1 (en) 2004-11-02
NZ527099A (en) 2004-09-24
ES2266500T3 (es) 2007-03-01
ATE329915T1 (de) 2006-07-15
WO2002057264A1 (en) 2002-07-25
NO20033290D0 (no) 2003-07-21
CZ20031949A3 (cs) 2003-12-17
EG23054A (en) 2004-02-29
KR20030076619A (ko) 2003-09-26
SK9282003A3 (en) 2004-04-06
CN1553911A (zh) 2004-12-08
EP1377577B1 (en) 2006-06-14
RU2003122364A (ru) 2005-03-27
NO20033290L (no) 2003-09-11
CN100371336C (zh) 2008-02-27
AR032511A1 (es) 2003-11-12
DE60212357T2 (de) 2007-05-31
PE20030197A1 (es) 2003-03-12
EP1377577A1 (en) 2004-01-07
MXPA03006515A (es) 2003-10-15
HUP0302807A2 (hu) 2003-12-29
DE60212357D1 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
BR0213140A (pt) Fungicidas de pirazol-pirimidina
DK7280A (da) Fremgangsmaade til fremstilling af (piperidinylalkyl) quinazolin-derivater
CY1108019T1 (el) Ενωσεις πυριμιδινης
TW200612920A (en) Novel imidazolidine derivatives
RS20060315A (en) Derivatives of n-/phenyl(pyrrolidine-2-yl) methyl/benzamide, and n- /(azepan-2-yl)phenylmethyl/benzamide, preparation method thereof and application of same in therapeutics
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
DK1414302T3 (da) 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe
WO2007053131A3 (en) Acrylamide derivatives as antibiotic agents
CY1114767T1 (el) Ν,ν-υποκατεστημενες ενωσεις 3-αμινοπυρρολιδινης χρησιμες ως αναστολεις επαναπροσληψης μονοαμινων
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
EP1057819A4 (en) PHTALAZINE DERIVATIVES AND REMEDIES FOR DYSERECTION
AR041605A1 (es) Compuesto 1- sustituido-4-nitroimidazol y metodo para preparar el mismo
BR0206650A (pt) Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto
TW200619201A (en) Process for the preparation of pyrazoles
DE60201089D1 (de) 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine
PE20000734A1 (es) Compuestos heterociclicos derivados de furopiridina y su uso terapeutico
YU74201A (sh) Nova sinteza prstena piperazina
AU6594900A (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents
DE60015817D1 (en) 6-phenyl-pyrazolpyrimidine
HUP0100740A2 (hu) Eljárás szubsztituált benzoil-cianid-amidinohidrazonok előállítására
WO2000064902A3 (en) Process for the preparation of calanolide precursors
DK1000952T3 (da) Nye 2-halogen-derivater af 5-O-deosaminylerythronolid A, fremgangsmåde til fremstilling deraf samt anvendelse deraf som lægemidler
UA83638C2 (ru) Соединения 4-оксо-4,6,7,8-тетрагидропирроло[1,2-a]пиразин-6-карбоксамида, способ их получения и фармацевтическая композиция, которая их содержит
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
PT1572198E (pt) Novos compostos farmaceuticos com actividade de receptor alfa2.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.